Stock Comparison

EXAS vs TDOC

Exact Sciences Corp vs Teladoc Health Inc

The Verdict

EXAS takes this one.

Winner
EXAS

Exact Sciences Corp

5.2

out of 10

Proceed with Caution
TDOC

Teladoc Health Inc

4.3

out of 10

Proceed with Caution

Head-to-Head

$16.1B

Market Cap

$1.4B
N/A

P/E Ratio

2.0
N/A

Profit Margin

-6.8%
N/A

Return on Equity

-12.4%
N/A

Debt-to-Equity

0.7
Aggressive

Overall Risk

Aggressive
5.2

DVR Score

4.3

The Deep Dive

EXAS5.2/10

Exact Sciences continues to demonstrate robust growth in established diagnostics like Cologuard, leveraging its strong market position and commercial infrastructure. The long-term vision for multi-cancer early detection (MCED) taps into a massive, transformative market, offering substantial upside potential. Leadership is strong, and financial health is improving, enabling continued investment in ...

Full EXAS Analysis
TDOC4.3/10

Teladoc Health operates in a vast virtual care market with a compelling whole-person health vision, but recent Q1 2026 results show significant headwinds. Revenue declined 2.5% YoY, and free cash flow was a notable -$26.3 million outflow, indicating persistent cash burn and challenging top-line execution. While operating margins improved, overall profitability remains elusive. Competitive advantag...

Full TDOC Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.

New member exclusive offer

Sign up free — members unlock an exclusive 44% off Premium deal